Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA releases Guidance for Industry on Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics

americanpharmaceuticalreviewDecember 20, 2018

Tag: FDA , Biologics , Clinical Trial

PharmaSources Customer Service